Pierre Gravier, CHIEF FINANCIAL OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 5,032 shares at $49.46 ($249K) on 2025-07-15, disclosed to the SEC on 2025-07-17.
Scheduled sale ($249k) by CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.46 | 2,516 | $124K | 50.0% |
| 2 | $49.46 | 2,516 | $124K | 50.0% |
| Total | $49.46 avg | 5,032 | $249K | 100% |
| Filing → |
| PTCT | SELL | 2026-01-08 | $165K | — | Filing → |
| PTCT | SELL | 2025-02-21 | $234K | — | Filing → |
| PTCT | SELL | 2024-07-18 | $154K | — | Filing → |